Gelesis ^Investors

Gelesis is an innovative company based in Boston, Massachusetts, established in 2006 The firm specializes in the development of novel therapies for weight management and metabolic health Gelesis has successfully raised a total investment of $276,000,000, reflecting significant confidence from investors in its potential to transform the healthcare landscape The company is committed to advancing its research and product offerings to improve the quality of life for individuals facing obesity and related conditions